Lyme disease is transmitted by the bite of certain Ixodes ticks, which can also transmit Anaplasma phagocytophilum, the cause of human granulocytic anaplasmosis (HGA). Although culture can be used to identify patients infected with A. phagocytophilum and is the microbiologic gold standard, few studies have evaluated culture-confirmed patients with HGA. We conducted a prospective study in which blood culture was used to detect HGA infection in patients with a compatible clinical illness. Early Lyme disease was defined by the presence of erythema migrans. The epidemiologic, clinical, and laboratory features of 44 patients with culture-confirmed HGA were compared with those of a convenience sample of 62 patients with early Lyme disease. Coinfected patients were excluded. Patients with HGA had more symptoms (P ؍ 0.003) and had a higher body temperature on presentation (P < 0.001) than patients with early Lyme disease. HGA patients were also more likely to have a headache, dizziness, myalgias, abdominal pain, anorexia, leukopenia, lymphopenia, thrombocytopenia, or elevated liver enzymes. A direct correlation between the number of symptoms and the duration of illness at time of presentation (rho ؍ 0.389, P ؍ 0.009) was observed for HGA patients but not for patients with Lyme disease. In conclusion, although there are overlapping features, culture-confirmed HGA is a more severe illness than early Lyme disease.
Human granulocytic anaplasmosis (HGA) and Lyme disease typically occur in the same geographic areas since both are acquired by the bite of infected Ixodes ticks (1-5). The etiologic agents, however, are quite different. HGA is caused by Anaplasma phagocytophilum, an obligate intracellular bacterium, whereas Lyme disease is caused by an extracellular spirochetal bacterium, Borrelia burgdorferi (1, 2).The hallmark of early Lyme disease is a distinctive annular erythematous skin lesion, called erythema migrans, that occurs at the site of tick inoculation of B. burgdorferi. Erythema migrans usually can be diagnosed clinically without the need for laboratory confirmation (1). In contrast, HGA is not known to be associated with a distinctive clinical feature, and therefore, laboratory testing is required to establish the diagnosis (2-5).Although A. phagocytophilum can be cultured in vitro, few laboratories offer such testing. Consequently, most of the reported cases have been diagnosed serologically or through PCR detection of A. phagocytophilum DNA. These laboratory methods, while generally reliable, are not necessarily equivalent to the diagnostic gold standard in microbiology of a positive culture. No systematic comparison of culture-confirmed HGA with Lyme disease has been reported. In this study, we compare the epidemiologic, clinical, and laboratory features of culture-confirmed HGA with those of early Lyme disease.
MATERIALS AND METHODSStudy design. This was a prospective, observational study that recorded the baseline epidemiologic, clinical, and laboratory features of patients with culture-confirmed HGA ...